Cash flow Statement
(Quarterly, GAAP
in millions $) |
(Sep 30 2022)
9 Months |
(Jun 30 2022)
6 Months |
(Mar 31 2022)
3 Months |
(Dec 31 2021)
12 Months |
|
| Income |
-29.76 |
-23.26 |
-5.15 |
-13.19 |
- |
| Depreciation & amortization |
1.39 |
1.17 |
1.00 |
3.61 |
- |
| Amortization of Other Assets |
- |
- |
- |
- |
- |
| Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense
|
- |
- |
- |
- |
- |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset |
-0.51 |
-0.84 |
-0.85 |
-1.78 |
- |
| Provision for Loan, Lease, and Other Losses |
- |
- |
- |
- |
- |
| Inventories Decrease /-Increase |
-0.02 |
-0.03 |
0.07 |
-0.24 |
- |
| R & D, Environmental and Other Expense |
- |
- |
- |
- |
- |
| Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal |
- |
-6.28 |
- |
- |
- |
| Issuance of Stock and Warrants for Services or Claims |
0.01 |
0.01 |
0.02 |
0.79 |
- |
| Income (Loss) from Equity Method Investments |
- |
- |
- |
-0.05 |
- |
| Financial Instruments and Foreign Currency Transaction |
- |
- |
- |
- |
- |
| Stock Issued During Period Value Issued For Services |
- |
- |
- |
- |
- |
| Loss From Joint Venture |
- |
- |
- |
- |
- |
| Indefinite Lived Intangible Assets Written Off Related To Sale Of Business Unit |
- |
- |
- |
- |
- |
| Shortterm Debt Average Outstanding Amount |
- |
- |
- |
- |
- |
| Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value |
- |
- |
- |
- |
- |
| Net Income Loss Attributable To Redeemable Noncontrolling Interest |
- |
- |
- |
- |
- |
| Stock Granted During Period Value Sharebased Compensation Gross |
- |
- |
- |
- |
- |
| Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments |
- |
- |
- |
- |
- |
| Loss On Conversion Of Convertible Promissory Notes |
- |
- |
- |
- |
- |
| Warrant Expense Fromconvertible Promissory Notes |
- |
- |
- |
- |
- |
| Inventory Reserve For Obsolesce |
- |
- |
- |
- |
- |
| Warrants Granted For Broker Fee Expense |
- |
- |
- |
- |
- |
| Cashless Exercise Of Warrants |
- |
- |
- |
- |
- |
| Finance Lease Right Of Use Asset Amortization |
0.07 |
0.05 |
- |
- |
- |
| Recovery Of Bad Debt Expense |
- |
- |
- |
- |
- |
| Inventory Reserve For Obsolescence |
- |
- |
0.01 |
- |
- |
| Gain From Desconsolidation Of Oak Therapeutics Inc |
- |
- |
- |
- |
- |
| Operating Lease Payments |
- |
- |
- |
- |
- |
| Gain From Settlement Of Accounts Payable |
- |
- |
-0.08 |
- |
- |
| Change In Fair Value Of Convertible Promissory Notes |
- |
0.31 |
0.28 |
- |
- |
| Fair Value Of Vested Stock Options And Restricted Stock |
1.41 |
0.87 |
0.46 |
- |
- |
| Income taxes |
- |
- |
- |
- |
- |
| Losses/ -gains on Investments net |
- |
- |
- |
- |
- |
| Increase (Decrease) in Accounts Receivable |
-0.07 |
-0.19 |
-0.11 |
-0.17 |
- |
| Increase (Decrease) in Accounts Payable |
-1.18 |
0.39 |
0.36 |
0.74 |
- |
| Increase (Decrease) in Accrued Liabilities |
-2.01 |
-0.71 |
-0.59 |
2.82 |
- |
| Deferred Revenue and Customer Advances and Deposits |
- |
- |
- |
- |
- |
| Increase (Decrease) in Prepaid Expenses, Other |
-0.06 |
0.08 |
0.05 |
- |
- |
| Other Working Capital |
5.01 |
5.73 |
0.00 |
-0.04 |
- |
| Other Noncash Items |
- |
- |
- |
- |
- |
| Other net |
- |
- |
- |
- |
- |
| Payments for (Proceeds from) Other Operating Activities |
24.21 |
19.14 |
2.71 |
0.05 |
- |
| Discontinued operations |
-6.97 |
- |
- |
- |
- |
| Net Cash flow from
Operating Activities |
-8.49 |
-3.57 |
-1.83 |
-4.32 |
- |
| Capital Expenditures |
- |
- |
- |
0.05 |
- |
| Sale of Capital Items |
- |
- |
- |
- |
- |
| Short-term Investments Proceeds |
- |
- |
- |
- |
- |
| Short-term Investments Acq. |
- |
- |
- |
- |
- |
| Real Estate Investments |
- |
- |
- |
- |
- |
| Proceeds From Common Stock Issuance For Acquisition Of Chemistry Holdings Inc |
- |
- |
- |
- |
- |
| Restricted Cash and Investments Increase (Decrease) |
- |
- |
- |
- |
- |
| Payments for (Proceeds from) Loans |
- |
- |
- |
- |
- |
| Payments for (Proceeds from) Deposits |
- |
- |
- |
- |
- |
| Payments for (Proceeds from) Other Investments |
13.89 |
- |
- |
- |
- |
| Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank |
- |
- |
- |
- |
- |
| Acquisition Net of Cash Acquired |
- |
- |
- |
- |
- |
| Interest in Subsidiaries and Affiliates |
- |
- |
- |
- |
- |
| Sale of businesses |
- |
- |
- |
- |
- |
| Accounts payable |
- |
- |
- |
- |
- |
| Receivables |
- |
- |
- |
- |
- |
| Payments for (Proceeds from) Other Investing Activities |
- |
- |
- |
- |
- |
| Other Net |
- |
- |
- |
-0.22 |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Net Cash flow from
Investing Activities |
13.89 |
- |
- |
-0.18 |
- |
| Short-term debt Net |
-2.23 |
0.25 |
2.25 |
2.02 |
- |
| Other borrowing transactions |
- |
- |
- |
- |
- |
| Long-term debt - borrowings |
0.23 |
0.19 |
0.19 |
0.49 |
- |
| Long-term debt - repayments |
-3.13 |
- |
- |
- |
- |
| Federal Home Loan Bank and Federal Funds |
- |
- |
- |
- |
- |
| Issuances/ -repurchases
of Comm. Stock |
- |
- |
- |
- |
- |
| Partnership and Parent Transactions |
- |
- |
- |
- |
- |
| Issuances/ -repurchases
of Pref. Stock |
- |
- |
- |
- |
- |
| Deposits, Annuities, Contract Holders Funds |
- |
- |
- |
- |
- |
| Other financing activities net |
- |
- |
- |
- |
- |
| Other net |
4.15 |
3.16 |
-0.09 |
0.28 |
- |
| Proceeds From Stock Payable |
- |
- |
- |
- |
- |
| Proceeds From Payroll Protection Program Loan |
- |
- |
- |
- |
- |
| Payments of Dividends, Preferred Stock and Preference Stock |
- |
- |
- |
- |
- |
| Dividends paid |
- |
- |
- |
- |
- |
| Net Cash flow from
Financing Activities |
-0.98 |
3.61 |
2.35 |
2.78 |
- |
| Effect of exchange rate on cash flow |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Free
Cash Flow |
-8.49 |
-3.57 |
-1.83 |
-4.27 |
- |
| Total Cash Flow |
4.43 |
0.04 |
0.52 |
-1.71 |
- |
| Cash & cash equiv. at beg.
of the Year |
- |
- |
0.02 |
1.73 |
- |
| Cash & cash equivalents at
end of period |
- |
- |
- |
- |
- |
| Cash Interests paid |
- |
- |
- |
- |
- |
| Cash Income taxes paid |
- |
- |
- |
- |
- |
